BaCKGround: Pneumococcal peritonitis is uncommon and poorly understood. Methods: As part of a five-year study (2000 to 2004) of invasive pneumococcal disease (IPD) in Alberta, all cases of peritonitis due to Streptococcus pneumoniae were reviewed and compared with all other cases of IPD. results: Twenty-three of 1768 (1.3%) IPD patients were found to have peritonitis. Patients with peritonitis were more likely to have cirrhosis, hepatitis C, alcoholism and HIV/AIDS, than the remainder of the patients with IPD. The all-cause mortality did not differ between the two groups. Peritonitis was classified as primary in nine (39%) patients, secondary in 12 (52%) patients, and genitourinary in females, specifically, in two (9%) patients. Pneumococcal serotypes causing peritonitis were under-represented in current vaccines -17% among peritonitis patients versus 53% for the remainder of IPD patients for the 7-valent pneumococcal conjugate vaccine, and 56% versus 86% for the 23-valent pneumococcal polysaccharide vaccine. ConClusIons: Peritonitis represents a small subset of patients with IPD, but one that is likely to grow in importance given the increase in the number of patients with hepatitis C and HIV, and the reduced coverage of peritonitis serotypes in currently available vaccines. isolates to the National Centre for Streptococcus (NCS) located in Edmonton, Alberta, for capsular serotyping and antimicrobial resistance testing. To ensure that case ascertainment was as complete as possible during the study period, all reported IPD cases were identified from the NCS, the provincial health office and two active-surveillance research projects -the Community Acquired Pneumonia Study (CAPS) in Edmonton, and the Calgary S pneumoniae Epidemiology Research (CASPER) study in Calgary, Alberta. Data from these four sources were combined to form the complete data set. Cases found in more than one source were counted once only.
data collection and definition of pneumococcal peritonitis
Trained research nurses reviewed the clinical records of all patients with IPD and recorded the data using standardized case report forms. The data were entered into FileMaker Pro version 8.5 (FileMaker Inc, USA) and transferred to SPSS version 11 (SPSS Inc, USA) for analysis.
The subset of patients with pneumococcal peritonitis were defined as those with a clinical diagnosis of peritonitis (abdominal pain with guarding and tenderness to palpation), and S pneumoniae isolated from the blood and/or peritoneal fluid. The records were re-reviewed by one of the authors (TJM) to ensure that the case definition was met.
Peritonitis was classified as primary; with an apparent genitourinary focus in young females; and secondary, as described by Capdevila et al (1) .
serotyping of pneumococcal isolates
Isolates received at the NCS were confirmed to be S pneumoniae using optochin susceptibility and bile solubility assays (7) . Serotyping of all pneumococcal isolates was performed at the NCS by the Quellung reaction using commercial antisera obtained from the Statens Serum Institut in Copenhagen, Denmark (8) . Isolates were categorized as those included in the 7-valent protein conjugate vaccine ( 4, 6B, 9V, 14, 18C, 19F, 23F), 7-valent protein conjugate vaccine related (6A, 19A) and those in the 23-valent polysaccharide vaccine (1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 13, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, 33F).
antimicrobial susceptibility assays
Antibiotic susceptibility was determined using reference broth microdilution methods as recommended by the Clinical and Laboratory Standards Institute guidelines (9) . The following antimicrobial agents were assayed: penicillin, ceftriaxone, chloramphenicol, erythromycin, clindamycin, tetracycline, trimethoprim-sulfamethoxazole, levofloxacin and vancomycin. All antimicrobial agents were purchased from Sigma-Aldrich Canada Ltd. The minimum inhibitory concentrations used to interpret susceptibility for S pneumoniae were those that were current at the time that the assay was performed (9) .
results
There were 1768 IPD patients during the period under surveillance, of which 23 (1.3%) had peritonitis. Table 1 provides a comparison of patients with peritonitis with those who had other manifestations of IPD. The analysis showed an over-representation of Aboriginal persons and, as expected, 39% of patients with peritonitis had cirrhosis compared with only 3% of the remaining IPD patients. Hepatitis C was the major cause of liver disease among the patients with peritonitis (22%) compared with the remaining IPD patients (6%), and there was a high rate of admission to surgery at 22% versus 2% for the remainder of the cases. Also, patients with HIV/AIDS were over-represented among the patients with peritonitis compared with the remaining IPD patients (13% versus 3%). The all-cause mortality rate of 25% among the peritonitis patients was not significantly higher than that of 13% for the remainder of the IPD patients. All vaccine serotypes had a much lower frequency in the peritonitis patients versus those with other manifestations of IPD, as shown in Table 1 . Table 2 details the clinical features for each patient. Only five isolates were from the peritoneal fluid. which in part, was due to the presence of ascites in only nine patients. While there were six patients with nephrotic syndrome in the entire study, only two had peritonitis.
The mean (± SD) length of stay of 13±12.8 days for patients with peritonitis was not significantly longer than the 8±25 days for the other patients.
Fifteen isolates were available for susceptibility testing (eight were not submitted to our laboratory). Ten of the isolates were from blood, and five were from peritoneal fluid. All isolates assayed were susceptible to penicillin, ceftriaxone, chloramphenicol, tetracycline, vancomycin, clindamycin and levofloxacin. Three (20%) were resistant to erythromycin and two were of intermediate susceptibility to trimethoprim-sulfamethoxazole. In comparison, data from the nonperitonitis IPD patients revealed that 9.7% of the isolates were resistant to penicillin, 8.3% to erythromycin and 18.8% to trimethoprimsulfamethoxazole. Table 2 shows selected data for all 23 patients. Four were children, two of whom had nephrotic syndrome as a predisposing cause. What is evident from the table is the complexity of the patients. Only the two patients classified as (1), 52% of our patients had secondary peritonitis, 39% had primary peritonitis and 9% were young females who had peritonitis presumably due to an ascending infection through the genital tract (11) . Hemsley and Eykyn (11) , in a review of the literature from 1995 to 1998, noted only 27 cases of pneumococcal peritonitis in women who were otherwise healthy. In this group, 13 of 17 (76%) patients who had blood cultures performed had S pneumoniae bacteremia. Seven had pelvic inflammatory disease, six had appendicitis, six had intrauterine contraceptive devices and two occurred postpartum. Patient 10 had a pelvic abscess and no other co morbidities. Patient 1 was a two-year-old girl who fit the original description of primary pneumococcal peritonitis.
Nielsen et al (12) identified 18 cases of pneumococcal peritonitis over five years in two Danish counties. They proposed a new classification of pneumococcal peritonitis: children -33% of their patients fit this category; women of child-bearing age -44%; and older patients -22%. Applying this classification to our patients, 17% were children, 22% were women of childbearing age and 61% were older patients.
Three (13%) of the patients in our study had HIV/AIDS, all of whom were also hepatitis C positive. Because HIV/AIDS has become a chronic disease with the advent of effective antiretroviral therapy, pneumococcal peritonitis will be an increasingly frequent complication of HIV/AIDS further complicated by hepatitis C (13, 14) . Indeed, cirrhotic patients with HIV and spontaneous bacterial peritonitis have a higher rate of S pneumoniae infection as the etiological agent of the peritonitis compared with non-HIV-infected patients (14) . The long-term prognosis for HIV/AIDS patients with pneumococcal peritonitis is poor (14) .
Spontaneous bacterial peritonitis is also known to be a severe complication of nephrotic syndrome, and yet one that despite being characteristic in children, tends to be rare in adults (15) (16) (17) . S pneumoniae is the most common causative agent of spontaneous bacterial peritonitis in patients with nephrotic syndrome (15) .
In our study, one patient had rheumatoid arthritis and one patient had lupus, an autoimmune disorder that has been diagnosed in increased incidence in patients with pneumococcal peritonitis (18) . Our patient with rheumatoid arthritis also had alcoholism and cirrhosis.
Seven (30%) of our patients had cirrhosis, pneumonia and alcoholism. In a cirrhotic rat model of pneumococcal pneumonia, early and late defects in killing S pneumoniae were identified (19) . It is well known that alcoholism is a risk factor for acquisition of pneumonia and for severity of pneumonia (20) (21) (22) . Thus, there is double jeopardy for some of these patients. In all likelihood, peritonitis results from the hematogenous spread of S pneumoniae in this subset of patients (1) .
Some cases of pneumococcal peritonitis can be nosocomial and can be precipitated by gastrointestinal bleeding (23) . Five of our patients had gastrointestinal bleeding.
The pneumococcal serotypes that caused peritonitis in our patients are under-represented in all currently marketed vaccines for S pneumoniae, indicating that such vaccines are unlikely to eliminate pneumococcal peritonitis.
While the isolates that were available for antimicrobial susceptibility testing from the peritonitis patients were all susceptible to penicillin, the missing isolates limit the conclusion that we can draw from this observation.
We conclude that pneumococcal peritonitis is a small, but distinct subset of patients with IPD, and one that is likely to grow in importance given the increase in the number of patients with hepatitis C and HIV.
